|
1.
|
Mok TS, Wu YL, Thongprasert S, et al:
Gefitinib or carboplatinpaclitaxel in pulmonary adenocarcinoma. N
Engl J Med. 361:947–957. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Mitsudomi T, Morita S, Yatabe Y, et al:
Gefitinib versus cisplatin plus docetaxel in patients with
non-small-cell lung cancer harbouring mutations of the epidermal
growth factor receptor (WJTOG3405): an open label, randomised phase
3 trial. Lancet Oncol. 11:121–128. 2010. View Article : Google Scholar
|
|
3.
|
Maemondo M, Inoue A, Kobayashi K, et al:
Gefitinib or chemotherapy for non-small-cell lung cancer with
mutated EGFR. N Engl J Med. 362:2380–2388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Zhou C, Wu Y-L, Chen G, et al: Erlotinib
versus chemotherapy as first-line treatment for patients with
advanced EGFR mutation-positive non-small-cell lung cancer
(OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase
3 study. Lancet Oncol. 12:735–742. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Rosell R, Carcereny E, Gervais R, et al:
Erlotinib versus standard chemotherapy as first-line treatment for
European patients with advanced EGFR mutation-positive
non-small-cell lung cancer (EURTAC): a multicentre, open-label,
randomised phase 3 trial. Lancet Oncol. 13:239–246. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Querings S, Altmuller J, Ansen S, et al:
Benchmarking of mutation diagnostics in clinical lung cancer
specimens. PLoS One. 6:e196012011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Marchetti A, Felicioni L and Buttitta F:
Assessing EGFR mutations. N Engl J Med. 354:526–528. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Takano T, Ohe Y, Tsuta K, et al: Epidermal
growth factor receptor mutation detection using high-resolution
melting analysis predicts outcomes in patients with advanced non
small cell lung cancer treated with gefitinib. Clin Cancer Res.
13:5385–5390. 2007. View Article : Google Scholar
|
|
9.
|
Do H, Krypuy M, Mitchell P, Fox S and
Dobrovic A: High resolution melting analysis for rapid and
sensitive EGFR and KRAS mutation detection in formalin fixed
paraffin embedded biopsies. BMC Cancer. 8:1422008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Fukui T, Ohe Y, Tsuta K, et al:
Prospective study of the accuracy of EGFR mutational analysis by
high-resolution melting analysis in small samples obtained from
patients with non-small cell lung cancer. Clin Cancer Res.
14:4751–4757. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Didelot A, Le Corre D, Luscan A, et al:
Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR
mutation detection in clinical formalin fixed paraffin embedded
samples. Exp Mol Pathol. 92:275–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kimura H, Kasahara K, Kawaishi M, et al:
Detection of epidermal growth factor receptor mutations in serum as
a predictor of the response to gefitinib in patients with
non-small-cell lung cancer. Clin Cancer Res. 12:3915–3921. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Lin CH, Yeh KT, Chang YS, Hsu N and Chang
JG: Rapid detection of epidermal growth factor receptor mutations
with multiplex PCR and primer extension in lung cancer. J Biomed
Sci. 17:372010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Dufort S, Richard M-J, Lantuejoul S and de
Fraipont F: Pyrosequencing, a method approved to detect the two
major EGFR mutations for anti EGFR therapy in NSCLC. J Exp Clin
Cancer Res. 30:572011. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Ellison G, Donald E, McWalter G, et al: A
comparison of ARMS and DNA sequencing for mutation analysis in
clinical biopsy samples. J Exp Clin Cancer Res. 29:132–139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Goto K, Satouchi M, Ishii G, et al: An
evaluation study of EGFR mutation tests utilized for non-small-cell
lung cancer in the diagnostic setting. Ann Oncol. 23:2914–2919.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Ellison G, Zhu G, Moulis A, Dearden S,
Speake G and McCormack R: EGFR mutation testing in lung cancer: a
review of available methods and their use for analysis of tumour
tissue and cytology samples. J Clin Pathol. 66:79–89. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Denis MG, Theoleyre S, Chaplais C, et al:
Efficient detection of EGFR alterations in lung adenocarcinomas.
ASCO Meeting abstracts. 28:105562010.
|
|
19.
|
Sun P-L, Seol H, Lee HJ, et al: High
incidence of EGFR mutations in Korean men smokers with no
intratumoral heterogeneity of lung adenocarcinomas: correlation
with histologic subtypes, EGFR/TTF-1 expressions, and clinical
features. J Thorac Oncol. 7:323–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Leary AF, Castro DGd, Nicholson AG, et al:
Establishing an EGFR mutation screening service for non-small cell
lung cancer - sample quality criteria and candidate histological
predictors. Eur J Cancer. 48:61–67. 2012. View Article : Google Scholar
|
|
21.
|
Castro AS, Parente B, Goncalves I, et al:
Epidermal growth factor recetor mutation study for 5 years, in a
population of patients with non-small cell lung cancer. Rev Port
Pneumol. 19:7–12. 2013.PubMed/NCBI
|
|
22.
|
Rosell R, Moran T, Queralt C, et al:
Screening for epidermal growth factor receptor mutations in lung
cancer. N Engl J Med. 361:958–967. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Lynch TJ, Bell DW, Sordella R, et al:
Activating mutations in the epidermal growth factor receptor
underlying responsiveness of non small-cell lung cancer to
gefitinib. N Engl J Med. 350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Paez JG, Janne PA, Lee JC, et al: EGFR
mutations in lung cancer: correlation with clinical response to
gefitinib therapy. Science. 304:1497–1500. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Matsuo K, Ito H, Yatabe Y, et al: Risk
factors differ for non-small-cell lung cancers with and without
EGFR mutation: assessment of smoking and sex by a case-control
study in Japanese. Cancer Sci. 98:96–101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Shigematsu H, Lin L, Takahashi T, et al:
Clinical and biological features associated with epidermal growth
factor receptor gene mutations in lung cancers. J Natl Cancer Inst.
97:339–346. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Kosaka T, Yatabe Y, Endoh H, Kuwano H,
Takahashi T and Mitsudomi T: Mutations of the epidermal growth
factor receptor gene in lung cancer: biological and clinical
implications. Cancer Res. 64:8919–8923. 2004. View Article : Google Scholar
|
|
28.
|
Yatabe Y, Kosaka T, Takahashi T and
Mitsudomi T: EGFR mutation is specific for terminal respiratory
unit type adenocarcinoma. Am J Surg Pathol. 29:633–639. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Yatabe Y and Mitsudomi T: Epidermal growth
factor receptor mutations in lung cancers. Pathol Int. 57:233–244.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Ueno T, Toyooka S, Suda K, et al: Impact
of age on epidermal growth factor receptor mutation in lung cancer.
Lung Cancer. 78:207–211. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Choi YH, Lee JK, Kang HJ, et al:
Association between age at diagnosis and the presence of EGFR
mutations in female patients with resected non-small cell lung
cancer. J Thorac Oncol. 5:1949–1952. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Girard N, Sima CS, Jackman DM, et al:
Nomogram to predict the presence of EGFR activating mutation in
lung adenocarcinoma. Eur Respir J. 39:366–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Warth A, Penzel R, Brandt R, et al:
Optimized algorithm for Sanger sequencing-based EGFR mutation
analyses in NSCLC biopsies. Virchows Arch. 460:407–414. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Zhou Q, Zhang X-C, Chen Z-H, et al:
Relative abundance of EGFR mutations predicts benefit from
Gefitinib treatment for advanced non small-cell lung cancer. J Clin
Oncol. 29:3316–3321. 2011. View Article : Google Scholar : PubMed/NCBI
|
